ARCHIVES

Conversation With The Cancer Letter: How ASCO’s Guideline Differs—And Why

This article is from The Cancer Letter archive.

Vol. 38 No. 29 | July 20, 2012

Download PDF Visit The Full Archive

Related Articles

DeCosse: Colorectal Screening Could Save 6,000 Lives Per Year

November 29, 1991

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

September 7, 1990

Liver Transplants Extend Survival In Early-Stage Cancer

January 27, 2006

European regulators plan more rigorous rules for accelerated approval in cancer.

November 11, 2005

Senate committee approves Lester Crawford’s nomination for FDA Commissioner.

June 17, 2005

NIH Eyes FCRC For Intramural Space As Contract Recompetition Planning Nears

May 23, 1980